The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bowie, A. G.
Right arrow Articles by O’Neill, L. A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bowie, A. G.
Right arrow Articles by O’Neill, L. A. J.
The Journal of Immunology, 2000, 165: 7180-7188.
Copyright © 2000 by The American Association of Immunologists

Vitamin C Inhibits NF-{kappa}B Activation by TNF Via the Activation of p38 Mitogen-Activated Protein Kinase1

Andrew G. Bowie2 and Luke A. J. O’Neill

Department of Biochemistry, Trinity College, Dublin, Ireland

The transcription factor NF-{kappa}B is a central mediator of altered gene expression during inflammation, and is implicated in a number of pathologies, including cancer, atherosclerosis, and viral infection. We report in this study that vitamin C inhibits the activation of NF-{kappa}B by multiple stimuli, including IL-1 and TNF in the endothelial cell line ECV304 and in primary HUVECs. The induction of a NF-{kappa}B-dependent gene, IL-8, by TNF was also inhibited. The effect requires millimolar concentrations of vitamin C, which occur intracellularly in vivo, particularly during inflammation. Vitamin C was not toxic to cells, did not inhibit another inducible transcription factor, STAT1, and had no effect on the DNA binding of NF-{kappa}B. Inhibition by vitamin C was not simply an antioxidant effect, because redox-insensitive pathways to NF-{kappa}B were also blocked. Vitamin C was shown to block IL-1- and TNF-mediated degradation and phosphorylation of I-{kappa}B{alpha} (inhibitory protein that dissociates from NF-{kappa}B), due to inhibition of I-{kappa}B kinase (IKK) activation. Inhibition of TNF-driven IKK activation was mediated by p38 mitogen-activated protein kinase, because treatment of cells with vitamin C led to a rapid and sustained activation of p38, and the specific p38 inhibitor SB203580 reversed the inhibitory effect of vitamin C on IKK activity, I-{kappa}B{alpha} phosphorylation, and NF-{kappa}B activation. The results identify p38 as an intracellular target for high dose vitamin C.




This article has been cited by other articles:


Home page
Anesth. Analg.Home page
Y. Li, X. Zhang, B. Zhu, and Z. Xue
Desflurane Preconditioning Inhibits Endothelial Nuclear Factor-{kappa}-B Activation by Targeting the Proximal End of Tumor Necrosis Factor-{alpha} Signaling
Anesth. Analg., May 1, 2008; 106(5): 1473 - 1479.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
Y. Li and H. E. Schellhorn
New Developments and Novel Therapeutic Perspectives for Vitamin C
J. Nutr., October 1, 2007; 137(10): 2171 - 2184.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
I. D'Alimonte, V. Flati, M. D'Auro, E. Toniato, S. Martinotti, M. P. Rathbone, S. Jiang, P. Ballerini, P. Di Iorio, F. Caciagli, et al.
Guanosine Inhibits CD40 Receptor Expression and Function Induced by Cytokines and beta Amyloid in Mouse Microglia Cells
J. Immunol., January 15, 2007; 178(2): 720 - 731.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
A. W. Orr, J. M. Sanders, M. Bevard, E. Coleman, I. J. Sarembock, and M. A. Schwartz
The subendothelial extracellular matrix modulates NF-{kappa}B activation by flow: a potential role in atherosclerosis
J. Cell Biol., April 11, 2005; 169(1): 191 - 202.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Y. Han, J. A. Englert, R. Yang, R. L. Delude, and M. P. Fink
Ethyl Pyruvate Inhibits Nuclear Factor-{kappa}B-Dependent Signaling by Directly Targeting p65
J. Pharmacol. Exp. Ther., March 1, 2005; 312(3): 1097 - 1105.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Campbell, C. J. Ciesielski, A. E. Hunt, N. J. Horwood, J. T. Beech, L. A. Hayes, A. Denys, M. Feldmann, F. M. Brennan, and B. M. J. Foxwell
A Novel Mechanism for TNF-{alpha} Regulation by p38 MAPK: Involvement of NF-{kappa}B with Implications for Therapy in Rheumatoid Arthritis
J. Immunol., December 1, 2004; 173(11): 6928 - 6937.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
J. M. Carcamo, A. Pedraza, O. Borquez-Ojeda, B. Zhang, R. Sanchez, and D. W. Golde
Vitamin C Is a Kinase Inhibitor: Dehydroascorbic Acid Inhibits I{kappa}B{alpha} Kinase {beta}
Mol. Cell. Biol., August 1, 2004; 24(15): 6645 - 6652.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
R. N. Rubin, L. Navon, and P. A. Cassano
Relationship of Serum Antioxidants to Asthma Prevalence in Youth
Am. J. Respir. Crit. Care Med., February 1, 2004; 169(3): 393 - 398.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
K. W. Lee, H. J. Lee, Y.-J. Surh, and C. Y. Lee
Vitamin C and cancer chemoprevention: reappraisal
Am. J. Clinical Nutrition, December 1, 2003; 78(6): 1074 - 1078.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
R. W. Saeed, T. Peng, and C. N. Metz
Ascorbic Acid Blocks the Growth Inhibitory Effect of Tumor Necrosis Factor-{alpha} on Endothelial Cells
Experimental Biology and Medicine, July 1, 2003; 228(7): 855 - 865.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
I. Perez-Cruz, J. M. Carcamo, and D. W. Golde
Vitamin C inhibits FAS-induced apoptosis in monocytes and U937 cells
Blood, July 1, 2003; 102(1): 336 - 343.
[Abstract] [Full Text] [PDF]


Home page
J AndrolHome page
D. Sanocka, P. Jedrzejczak, A. Szumala-Kaekol, M. Fraczek, and M. Kurpisz
Male Genital Tract Inflammation: The Role of Selected Interleukins in Regulation of Pro-Oxidant and Antioxidant Enzymatic Substances in Seminal Plasma
J Androl, May 1, 2003; 24(3): 448 - 455.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. A. Carluccio, L. Siculella, M. A. Ancora, M. Massaro, E. Scoditti, C. Storelli, F. Visioli, A. Distante, and R. De Caterina
Olive Oil and Red Wine Antioxidant Polyphenols Inhibit Endothelial Activation: Antiatherogenic Properties of Mediterranean Diet Phytochemicals
Arterioscler. Thromb. Vasc. Biol., April 1, 2003; 23(4): 622 - 629.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
K. R. Morris, R. D. Lutz, H.-S. Choi, T. Kamitani, K. Chmura, and E. D. Chan
Role of the NF-{kappa}B Signaling Pathway and {kappa}B cis-Regulatory Elements on the IRF-1 and iNOS Promoter Regions in Mycobacterial Lipoarabinomannan Induction of Nitric Oxide
Infect. Immun., March 1, 2003; 71(3): 1442 - 1452.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
S. T. Ahmed, A. Mayer, J.-D. Ji, and L. B. Ivashkiv
Inhibition of IL-6 signaling by a p38-dependent pathway occurs in the absence of new protein synthesis
J. Leukoc. Biol., July 1, 2002; 72(1): 154 - 162.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
I. Bosch, K. Xhaja, L. Estevez, G. Raines, H. Melichar, R. V. Warke, M. V. Fournier, F. A. Ennis, and A. L. Rothman
Increased Production of Interleukin-8 in Primary Human Monocytes and in Human Epithelial and Endothelial Cell Lines after Dengue Virus Challenge
J. Virol., May 3, 2002; 76(11): 5588 - 5597.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. M. Carcamo, O. Borquez-Ojeda, and D. W. Golde
Vitamin C inhibits granulocyte macrophage-colony-stimulating factor-induced signaling pathways
Blood, May 1, 2002; 99(9): 3205 - 3212.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. Libby and M. Aikawa
Vitamin C, Collagen, and Cracks in the Plaque
Circulation, March 26, 2002; 105(12): 1396 - 1398.
[Full Text] [PDF]


Home page
Endocr. Rev.Home page
J. Pfeilschifter, R. Koditz, M. Pfohl, and H. Schatz
Changes in Proinflammatory Cytokine Activity after Menopause
Endocr. Rev., February 1, 2002; 23(1): 90 - 119.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.